Bicarbonates Versus Saline for Contrast Induced Acute Kidney Injury Prevention in Intensive Care Unit
NCT ID: NCT01636089
Last Updated: 2015-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
300 participants
INTERVENTIONAL
2012-02-29
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urine Alkalinisation to Prevent AKI in COVID-19
NCT04655716
Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis
NCT00752453
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units
NCT04459975
Uremic Toxins in the ICU: Patients After Cardiac Surgery
NCT00752804
Urine Alkalinisation in COVID-19
NCT04806061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bicarbonates
sodium bicarbonates 1,4%
bicarbonates
sodium bicarbonates 1,4%
saline
sodium chloride 0,9%
saline
sodium chloride 0,9%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bicarbonates
sodium bicarbonates 1,4%
saline
sodium chloride 0,9%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in intensive care unit since 24h and for up to 48 hours
* with contrast medium injection
Exclusion Criteria
* rise in creatinine \> 26µmol/L within 48hours
* anuria within 12 hours
* cardiogenic pulmonary oedema
* pH \> 7.50 or kaliemia \< 3mmol/L
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Intensive Care Unit
Caen, , France
Surgical Intensive Care Unit
Caen, , France
Intensive care unit
Saint-Lô, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00227-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.